Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B
Respiratory mucus contains a mixture of gel-forming mucins but the functional significance of these different mucin species is unknown. To help gain a better understanding of mucus in airways we therefore need to ascertain the concentration of each of the gel-forming mucins within respiratory secret...
Saved in:
| Published in: | Biochemical journal Vol. 361; no. Pt 3; p. 537 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
01.02.2002
|
| Subjects: | |
| ISSN: | 0264-6021 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Respiratory mucus contains a mixture of gel-forming mucins but the functional significance of these different mucin species is unknown. To help gain a better understanding of mucus in airways we therefore need to ascertain the concentration of each of the gel-forming mucins within respiratory secretions. Thus the aim of this study was to determine the amounts of specific gel-forming mucins directly from solubilized secretions of the airways and purified mucin preparations. We investigated the feasibility of using direct-binding ELISA employing mucin-specific antisera but were unable to obtain reliable data owing to interference with the immobilization of the mucins on the assay surface by 6 M urea and high levels of non-mucin proteins. We therefore developed an alternative approach based on quantitative Western blotting after agarose-gel electrophoresis, which was not subject to these problems. Here we demonstrate that this procedure provides reliable and reproducible data and have employed it to determine the amounts of the MUC2, MUC5AC and MUC5B mucins in saline-induced sputa from healthy airways and spontaneous sputa from asthmatic airways. Additionally we have used this procedure to analyse these glycoproteins in mucin preparations purified from cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) mucus. Our findings indicate that MUC5AC and MUC5B are the major oligomeric mucins and that airways mucus contains variable amounts of these glycoproteins. By contrast, the MUC2 mucin comprised, at most, only 2.5% of the weight of the gel-forming mucins, indicating that MUC2 is a minor component in sputum. Finally, we show that the amounts and glycosylated variants of the MUC5AC and MUC5B mucins can be altered significantly in diseased airways with, for instance, an increase in the low-charge form of the MUC5B mucin in CF and COPD mucus. |
|---|---|
| AbstractList | Respiratory mucus contains a mixture of gel-forming mucins but the functional significance of these different mucin species is unknown. To help gain a better understanding of mucus in airways we therefore need to ascertain the concentration of each of the gel-forming mucins within respiratory secretions. Thus the aim of this study was to determine the amounts of specific gel-forming mucins directly from solubilized secretions of the airways and purified mucin preparations. We investigated the feasibility of using direct-binding ELISA employing mucin-specific antisera but were unable to obtain reliable data owing to interference with the immobilization of the mucins on the assay surface by 6 M urea and high levels of non-mucin proteins. We therefore developed an alternative approach based on quantitative Western blotting after agarose-gel electrophoresis, which was not subject to these problems. Here we demonstrate that this procedure provides reliable and reproducible data and have employed it to determine the amounts of the MUC2, MUC5AC and MUC5B mucins in saline-induced sputa from healthy airways and spontaneous sputa from asthmatic airways. Additionally we have used this procedure to analyse these glycoproteins in mucin preparations purified from cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) mucus. Our findings indicate that MUC5AC and MUC5B are the major oligomeric mucins and that airways mucus contains variable amounts of these glycoproteins. By contrast, the MUC2 mucin comprised, at most, only 2.5% of the weight of the gel-forming mucins, indicating that MUC2 is a minor component in sputum. Finally, we show that the amounts and glycosylated variants of the MUC5AC and MUC5B mucins can be altered significantly in diseased airways with, for instance, an increase in the low-charge form of the MUC5B mucin in CF and COPD mucus.Respiratory mucus contains a mixture of gel-forming mucins but the functional significance of these different mucin species is unknown. To help gain a better understanding of mucus in airways we therefore need to ascertain the concentration of each of the gel-forming mucins within respiratory secretions. Thus the aim of this study was to determine the amounts of specific gel-forming mucins directly from solubilized secretions of the airways and purified mucin preparations. We investigated the feasibility of using direct-binding ELISA employing mucin-specific antisera but were unable to obtain reliable data owing to interference with the immobilization of the mucins on the assay surface by 6 M urea and high levels of non-mucin proteins. We therefore developed an alternative approach based on quantitative Western blotting after agarose-gel electrophoresis, which was not subject to these problems. Here we demonstrate that this procedure provides reliable and reproducible data and have employed it to determine the amounts of the MUC2, MUC5AC and MUC5B mucins in saline-induced sputa from healthy airways and spontaneous sputa from asthmatic airways. Additionally we have used this procedure to analyse these glycoproteins in mucin preparations purified from cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) mucus. Our findings indicate that MUC5AC and MUC5B are the major oligomeric mucins and that airways mucus contains variable amounts of these glycoproteins. By contrast, the MUC2 mucin comprised, at most, only 2.5% of the weight of the gel-forming mucins, indicating that MUC2 is a minor component in sputum. Finally, we show that the amounts and glycosylated variants of the MUC5AC and MUC5B mucins can be altered significantly in diseased airways with, for instance, an increase in the low-charge form of the MUC5B mucin in CF and COPD mucus. Respiratory mucus contains a mixture of gel-forming mucins but the functional significance of these different mucin species is unknown. To help gain a better understanding of mucus in airways we therefore need to ascertain the concentration of each of the gel-forming mucins within respiratory secretions. Thus the aim of this study was to determine the amounts of specific gel-forming mucins directly from solubilized secretions of the airways and purified mucin preparations. We investigated the feasibility of using direct-binding ELISA employing mucin-specific antisera but were unable to obtain reliable data owing to interference with the immobilization of the mucins on the assay surface by 6 M urea and high levels of non-mucin proteins. We therefore developed an alternative approach based on quantitative Western blotting after agarose-gel electrophoresis, which was not subject to these problems. Here we demonstrate that this procedure provides reliable and reproducible data and have employed it to determine the amounts of the MUC2, MUC5AC and MUC5B mucins in saline-induced sputa from healthy airways and spontaneous sputa from asthmatic airways. Additionally we have used this procedure to analyse these glycoproteins in mucin preparations purified from cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) mucus. Our findings indicate that MUC5AC and MUC5B are the major oligomeric mucins and that airways mucus contains variable amounts of these glycoproteins. By contrast, the MUC2 mucin comprised, at most, only 2.5% of the weight of the gel-forming mucins, indicating that MUC2 is a minor component in sputum. Finally, we show that the amounts and glycosylated variants of the MUC5AC and MUC5B mucins can be altered significantly in diseased airways with, for instance, an increase in the low-charge form of the MUC5B mucin in CF and COPD mucus. |
| Author | Kirkham, Sara Sheehan, John K Knight, David Richardson, Paul S Thornton, David J |
| Author_xml | – sequence: 1 givenname: Sara surname: Kirkham fullname: Kirkham, Sara organization: Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, School of Biological Sciences, 2.205, Stopford Building, Manchester M13 9PT, UK – sequence: 2 givenname: John K surname: Sheehan fullname: Sheehan, John K – sequence: 3 givenname: David surname: Knight fullname: Knight, David – sequence: 4 givenname: Paul S surname: Richardson fullname: Richardson, Paul S – sequence: 5 givenname: David J surname: Thornton fullname: Thornton, David J |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11802783$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kDtPwzAUhT0U0Qf8ABbkiS3gR-w43UrESypioXPkODfFVRIXOwHy72mgMJ2rc893hjNHk9a1gNAFJdeUxOyGMBlHkjC65JISwZMJmv17UzQPYUcIjUlMTtGUUkVYovgMfT1CB95toQXbDdhVWFv_qYeAm970YYk_tLe6s64N2La4ewOsG9e3XcC6LfG2HoyrnG_CiI7fRu-cx662W9eAt2bssQf4eZOJVfYDjeftGTqpdB3g_KgLtLm_e80eo_XLw1O2WkcmlrSLpBFpKohgBWguuZEVlDGFmJRMlIIpKDgVCWgSC15QojSvlJQp16ogyuiELdDVb-_eu_ceQpc3Nhioa92C60OeHDZJuRqDl8dgXzRQ5ntvG-2H_G8r9g2ZfGuM |
| CitedBy_id | crossref_primary_10_1016_j_biocel_2014_03_011 crossref_primary_10_1016_j_carbpol_2012_09_078 crossref_primary_10_1016_j_jaci_2007_01_005 crossref_primary_10_1089_153685903322538818 crossref_primary_10_1016_j_compstruc_2007_01_015 crossref_primary_10_1155_2016_7984853 crossref_primary_10_1016_j_chroma_2006_07_070 crossref_primary_10_1056_NEJMra0910061 crossref_primary_10_1016_j_pharmthera_2008_11_001 crossref_primary_10_1007_s11882_003_0046_1 crossref_primary_10_1063_1_4907705 crossref_primary_10_1128_spectrum_00459_22 crossref_primary_10_1016_j_pupt_2014_04_004 crossref_primary_10_1016_j_trsl_2012_08_001 crossref_primary_10_1183_09031936_00107811 crossref_primary_10_1128_AAC_02811_13 crossref_primary_10_1164_rccm_201101_0106OC crossref_primary_10_1111_j_1365_2559_2004_01952_x crossref_primary_10_1016_j_pupt_2009_08_004 crossref_primary_10_1007_s10787_012_0155_3 crossref_primary_10_1093_icb_icu107 crossref_primary_10_1016_j_ceca_2014_02_001 crossref_primary_10_1099_jmm_0_047167_0 crossref_primary_10_1016_j_tim_2013_04_008 crossref_primary_10_1208_s12249_008_9072_6 crossref_primary_10_1016_j_tiv_2008_07_009 crossref_primary_10_1159_000512268 crossref_primary_10_1007_s00418_011_0872_5 crossref_primary_10_3389_fcell_2021_663535 crossref_primary_10_3389_fphar_2020_554353 crossref_primary_10_1016_j_jaci_2009_05_037 crossref_primary_10_1016_j_pupt_2005_03_001 crossref_primary_10_3389_fphar_2023_1236550 crossref_primary_10_1146_annurev_physiol_70_113006_100441 crossref_primary_10_1016_j_mehy_2009_10_044 crossref_primary_10_1016_j_vascn_2005_03_001 crossref_primary_10_1016_j_bbagen_2009_03_016 crossref_primary_10_1016_j_biocel_2012_10_011 crossref_primary_10_1084_jem_20102057 crossref_primary_10_1128_msphere_00365_25 crossref_primary_10_1016_S1155_195X_09_47939_8 crossref_primary_10_1089_omi_2010_0075 crossref_primary_10_1146_annurev_physiol_70_113006_100702 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1042/0264-6021:3610537 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry |
| ExternalDocumentID | 11802783 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 23N 2WC 3EH 3O- 4.4 53G 5GY 5RE 5VS 6J9 79B AABGO AAHRG ABJNI ABPPZ ABTAH ACGFO ACGFS ACNCT ADBBV AEGXH AENEX AI. AIAGR AIZAD ALMA_UNASSIGNED_HOLDINGS BAWUL CGR CS3 CUY CVF DU5 E3Z EBS ECM EIF EJD F5P H13 HH6 HYE HZ~ K-O L7B MV1 MVM N9A NPM O9- OHT OK1 P2P RHI RNS RPM RPO TR2 TWZ VH1 VXZ WH7 WOQ X7M XOL XSW Y6R YNY ZGI ZXP ZY4 ~02 ~KM 7X8 ADXHL |
| ID | FETCH-LOGICAL-c461t-6c5995052bea363c6fed41e40d25d528eb3157ea0453b108a3f86693a8b08ca72 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 281 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000173982700014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0264-6021 |
| IngestDate | Thu Jul 10 23:28:36 EDT 2025 Wed Feb 19 02:36:39 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | Pt 3 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c461t-6c5995052bea363c6fed41e40d25d528eb3157ea0453b108a3f86693a8b08ca72 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/1222336 |
| PMID | 11802783 |
| PQID | 71409387 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_71409387 pubmed_primary_11802783 |
| PublicationCentury | 2000 |
| PublicationDate | 2002-Feb-01 20020201 |
| PublicationDateYYYYMMDD | 2002-02-01 |
| PublicationDate_xml | – month: 02 year: 2002 text: 2002-Feb-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Biochemical journal |
| PublicationTitleAlternate | Biochem J |
| PublicationYear | 2002 |
| SSID | ssj0014040 |
| Score | 2.2338629 |
| Snippet | Respiratory mucus contains a mixture of gel-forming mucins but the functional significance of these different mucin species is unknown. To help gain a better... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 537 |
| SubjectTerms | Asthma - metabolism Blotting, Western Cystic Fibrosis - metabolism Dose-Response Relationship, Drug Electrophoresis, Agar Gel Enzyme-Linked Immunosorbent Assay Humans Mucin 5AC Mucin-5B Mucins - chemistry Mucins - metabolism Mucous Membrane - metabolism Mucus - metabolism Pulmonary Disease, Chronic Obstructive - metabolism Sputum - metabolism Urea - pharmacology |
| Title | Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/11802783 https://www.proquest.com/docview/71409387 |
| Volume | 361 |
| WOSCitedRecordID | wos000173982700014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB5RqNRegEJ5tbQ-oN4inNixvQipWlZFHMqKA1R7W40dGwWxMd2w0P33tb0beqp66CWKEk0UTSaebx6eD-DIOS0Y8jzTIsQm3OWYKUFlZoMzZlrSwqbt0T--y-FQjUa9qxU47fbCxLbKbk1MC3XlTcyRH8fBcj2m5NeHn1nkjIq11SWBxitYYwHIRJuWoz81BE75MsPCMxFc2UtNszh-uXbCAnwomfw7vkx-5nzj_95wE9aX-JL0FwbxDlZsswXb_SbE1pM5-UJSx2dKpW_Bm0HH9rYNvy5iX4wP5mQDLifeEaynzzhvyWRmZu0JeQpB9SK7R-qGBNhIcBJ5JlqCTUVu7-fGR_zbRtF4d4J3fkr8fX3rU1EoPqcOwpc3g7I_SELx9Ow93Jx_ux5cZEtWhsxwkT9mwsQZZbQstEUmmBHOVjy3nFZFWZWFCtF5XkqLASsynVOFzCkhegyVpsqgLHZgtfGN3QNCe5VWLI5Yc4ZTFKglCiU4ljovcnT78LnT9DioI5YysLF-1o47Xe_D7uJjjR8WwznGaaSdVOzgn7If4G2idkkt2B9hzYX_3R7Ca_P0WLfTT8mYwnF4dfkbjs3THQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Heterogeneity+of+airways+mucus%3A+variations+in+the+amounts+and+glycoforms+of+the+major+oligomeric+mucins+MUC5AC+and+MUC5B&rft.jtitle=Biochemical+journal&rft.au=Kirkham%2C+Sara&rft.au=Sheehan%2C+John+K&rft.au=Knight%2C+David&rft.au=Richardson%2C+Paul+S&rft.date=2002-02-01&rft.issn=0264-6021&rft.volume=361&rft.issue=Pt+3&rft.spage=537&rft_id=info:doi/10.1042%2F0264-6021%3A3610537&rft_id=info%3Apmid%2F11802783&rft_id=info%3Apmid%2F11802783&rft.externalDocID=11802783 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0264-6021&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0264-6021&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0264-6021&client=summon |